Increased cerebrospinal fluid glycine: A biochemical marker for a leukoencephalopathy with vanishing white matter

Journal of Child Neurology

Volumn 14, Issue 11, 1999, Pages 728-731

  Van Der Knaap, Marjo S ^a   Wevers, Ron A ^b   Kure, Shigeo ^c   Gabreëls, Fons J M ^b   Verhoeven, Nanda M ^a   Van Raaij Selten, Bertie ^b   Jaeken, Jaak ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE;

ADOLESCENT; ADULT; AMINO ACID METABOLISM; ARTICLE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; HUMAN; LEUKOENCEPHALOPATHY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WHITE MATTER;

EID: 0032732146     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901401108     Document Type: Article

References (37)

1. Hanefeld F, Holzbach U, Kruse B, et al: Diffuse white matter disease in three children: An encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics 1993;24:244-248.
2. Schifimann R, Möller JR, Trapp BD, et al: Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol 1994;35:331-340.
3. Tedeschi G, Schiffmann R, Barton NW, et al: Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination. Neurology 1995;45: 1526-1532.
4. Van der Knaap MS, Barth PG, Gabreëls FJM, et al: A new leukoencephalopathy with vanishing white matter. Neurology 1997;48: 845-855.
5. Van der Knaap MS, Kamphorst W, Barth PG, et al: Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998;51:540-547.
6. Gerrits GP, Trijbels FJ, Monnens LA, et al: Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorometric detection. Clin Chim Acta 1989;182:271-280.
7. Kure S, Narisawa K, Tada K: Enzymatic diagnosis of nonketotic hyperglycinemia with lymphoblasts. J Pediatr 1992;120:95-98.
8. Hamosh A, Johnston MV, Valle D: Nonketotic hyperglycinemia, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 1995, pp 1337-1348.
9. 3H]-strychnine. J Neurosci 1981;1:532-547.
10. Thomson AM: Glycine modulation of the NMDA receptor channel complex. Trends Neurosci 1989;12:349-353.
11. Rizzo V, Anesi A, Montalbetti L, et al: Reference values of neuroactive amino acids in the cerebrospinal fluid by high-performance liquid chromatography with electrochemical and fluorescence detection. J Chromatogr A 1996;729:181-188.
12. Meldrum BS: Excitatory amino acid receptors and disease. Curr Opin Neurol Neurosurg 1992;5:508-513.
13. Lipton SA, Rosenberg PA: Excitatory amino acids as final common pathway for neurologic disorders. N Engl J Med 1994;330: 613-622.
14. Castillo J, Dávalos A, Naveiro J, Noya M: Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27:1060-1065.
15. Yurdakök M, Coşkun T, Erdem G, et al: Cerebrospinal fluid amino acid levels in newborn infants with intracranial hemorrhage. Acta Paediatr Jpn 1995;37:694-696.
16. Palmer AM, Marion DW, Botscheller ML, et al: Increased transmitter amino acid concentration in human ventricular CSF after brain trauma. Neuroreport 1994;6:153-156.
17. Qureshi GA, Baig SM, Parvez SH: Biochemical markers in tuberculosis meningitis. Biogenic Amines 1996;12:499-519.
18. Mochizuki Y, Oishi M, Hara M, Takasu T: Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia. Ann Clin Lab Sci 1996;26:275-278.
19. Jiménez-Jiménez FJ, Molina JA, Vargas C, et al: Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 1996;141:39-44.
20. Nicoli F, Vion-Duiy J, Maloteaux JM, et al: CSF and serum metabolic profile of patients with Huntington's chorea: A study by high resolution proton NMR spectroscopy and HPLC. Neurosci Lett 1993;154:47-51.
21. Tohgi H, Abe T, Hashiguchi K, et al: A significant reduction of putative transmitter amino acids in the cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration. Neurosci Lett 1991;126:155-158.
22. Rothrock JF, Mar KR, Yaksh TL, et al: Cerebrospinal fluid analyses in migraine patients and controls. Cephalalgia 1995;15:489-493.
23. Tada K, Kure S: Nonketotic hyperglycinemia: Molecular lesion, diagnosis and pathophysiology. J Inherit Metab Dis 1993;16: 691-703.
24. Tada K: Nonketotic hyperglycinemia: Clinical and metabolic aspects. Enzyme 1987;38:27-35.
25. Hayasaka K, Tada K, Fueki N, et al: Nonketotic hyperglycinemia: Analysis of glycine cleavage system in typical and atypical cases. J Pediatr 1987;11:873-877.
26. Tada K, Hayasaka K: Nonketotic hyperglycinemia: Clinical and biochemical aspects. Eur J Pediatr 1987;146:221-227.
27. Christodoulou J, Kure S, Hayasaka K, Clarke JTR: Atypical non-ketotic hyperglycinemia confirmed by assay of the glycine cleavage system in lymphoblasts. J Pediatr 1993;123:100-102.
28. Singer HS, Valle D, Hayasaka K, Tada K: Nonketotic hyperglycinemia: Studies in an atypical variant. Neurology 1989;39: 286-288.
29. Slager UT, Berggren RLK, Marubayashi S: Nonketotic hyperglycinemia: Report of a case and review of the clinical, chemical and pathological changes. Ann Neurol 1977;1:399-402.
30. Brun A, Börjeson M, Hultberg B, et al: Neonatal non-ketotic hyperglycinemia: A clinical, biochemical and neuropathological study including electronmicroscopic findings. Neuropediatrics 1979;10: 195-205.
31. Bernardina BD, Aicardi J, Goutières F, Plouin P: Glycine encephalopathy. Neuropediatrics 1979;10:209-225.
32. Agamenolis DP, Potter JL, Herzick MK, Sternberger NH: The neuropathology of glycine encephalopathy: A report of five cases with immunohistochemical and ultrastructural observations. Neurology 1982;32:975-985.
33. Trauner DA, Page T, Greco C, et al: Progressive neurodegenerative disorder in a patient with nonketotic hyperglycinemia. J Pediatr 1981;98:272-275.
34. Press GA, Barshop BA, Haas RH, et al: Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. Am J Neuroradiol 1989;10:315-321.
35. Flannery DB, Pellock J, Bousounis D, et al: Nonketotic hyperglycinemia in two retarded adults: A mild form of infantile non-ketotic hyperglycinemia. Neurology 1983;33:1064-1066.
36. Steiner RD, Sweetser DA, Rohrbaugh JR, et al: Nonketotic hyperglycinemia: Atypical clinical and biochemical manifestations. J Pediatr 1996;128:243-246.
37. Shih VE: Amino acid analysis, in Blau N, Duran M, Blaskovics ME (eds): Physician's Guide to the Laboratory Diagnosis of Metabolic Disease. London, Chapman & Hall, 1996, pp 13-29.